ETA-DOC-0004·Compound index·Rev 1·Methodology v0.1Provisional — reviewer not yet appointed
compound index · B, page 1 of 5 · methodology v0.1 · reviewer not yet appointed
Compound index · B ETA-DOC-0004

Compound index — B

887 substances begin with B. 5 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, B-caroten – Benzenemethanol….

US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
B-caroten EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“The antioxidant action of beta-caroten helps to neutralize free radicals and counteracts cellular ageing. Beta-caroten is involved in body tissue protection from UV rays damage.”Non-authorisedArt.13(1)EFSA opinion
“The antioxidant action of beta-caroten helps to neutralize free radicals and counteracts cellular ageing. Beta-caroten is involved in body tissue protection from UV rays damage.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002137
B-sitosterol CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002138
B/Brisbane/60/2008-like strain (B/Brisbane/60/2008) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002129
B/Massachusetts/2/2012 like strain EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07BB03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002130
B/Pennsylvania/14/2025-like strain (B/Arizona/21/2025, wild type) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002131
B/Tokyo/EIS13-175/2025 - like strain (B/Perth/115/2025, MEDI 407730) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002132
B/Tokyo/EIS13-175/2025-like strain (B/Tokyo/EIS13-175/2025, wild type) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002133
B/Victoria EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07B
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002134
B/Victoria lineage EU-MED Not yet graded
EU medicine: Opinion
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002135
B/Yamagata lineage EU-MED Not yet graded
EU medicine: Opinion
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002136
babesia canis EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI07AO
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002139
Babesia Microti US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]
Market presence43 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002140
Babesia Microti DNA US-DRUG Not yet graded
US: drug for further processing
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002141
babesia rossi EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI07AO
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002142
Bacampicillin Hydrochloride US-DRUG Not yet graded
Earliest US approval1980
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002143
Baccharis Halimifolia Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence18 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002144
Baccharis Pilularis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002145
Baccharis Sarothroides Whole US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002146
Bacille of Morgan CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002147
Bacillinum pulmo CA-NHP Not yet graded
CA licensed ingredient
Market presence13 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002148
Bacillus Anthracis Immunoserum Rabbit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Allergens [CS]
Market presence28 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002149
Bacillus Anthracis Strain V770-NP1-R Antigens US-DRUG Not yet graded
US: bla
Class as recordedActively Acquired Immunity [PE]; Anthrax Vaccines [Chemical/Ingredient]; Attenuated [Chemical/Ingredient]; Live Attenuated Bacillus Anthracis Vaccine [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002150
Bacillus Calmette-Guerin Live Antigen, Unspecified Substrain US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Allergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002151
Bacillus Calmette-Guerin Substrain Tice Live Antigen US-DRUG Not yet graded
US: bla
Class as recordedActively Acquired Immunity [PE]; Attenuated [CS]; BCG Vaccine [CS]; Increased Immunologically Active Molecule Activity [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002152
Bacillus Cereus US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002153
Bacillus clausii CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
Market presence38 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-002154
Bacillus coagulans CA-NHP Not yet graded
CA licensed ingredient
Market presence874 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002155
Bacillus ferment filtrate extract CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002156
Bacillus Firmus US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002157
Bacillus indicus CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002158
Bacillus licheniformis CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002159
Bacillus No. 7 CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002160
Bacillus Subtilis CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in supplementsCA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence2 US product listings · 192 Canadian licensed products
Parts in scopeWhole
Recorded fromCA-NHP, EU-NOVEL, US-DRUG — 3 of 7 registers
Etalyn identifierETA-C-002161
Bacillus subtilis DE111 CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002162
Bacillus subtilis HU58 EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“• Contains Probiotic • Contains healthy bacteria • Maintains dominance of good bacteria in the gut”Non-authorisedArt.13(1)EFSA opinion
“• Contributes to/ supports / maintains natural resistance/defence • Strengthens your body's natural defence • Stimulates the immune system • Stimulates the specific and non specific immune system • Supports your natural defences • Helps to regulate the b”Non-authorisedArt.13(1)EFSA opinion
“• For good intestinal health • Helps keep your digestive system in balance • Helps gastrointestinal tract comfort • Maintains a healthy intestinal environment and functionality • Maintain the balance of microflora • Promotes and maintains intestinal hea”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002163
Bacillus subtilis Natto EU-CLAIM Not yet graded
EU claims 0 authorised / 3 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“• Helps support a healthy heart • Helps maintain a healthy heart”Non-authorisedArt.13(1)EFSA opinion
“• Contributes to/ supports / maintains natural resistance/defence • Strengthens your body's natural defence • Stimulates the immune system • Stimulates the specific and non specific immune system • Supports your natural defences • Helps to regulate the b”Non-authorisedArt.13(1)EFSA opinion
“• For good intestinal health • Helps keep your digestive system in balance • Helps gastrointestinal tract comfort • Maintains a healthy intestinal environment and functionality • Maintain the balance of microflora • Promotes and maintains intestinal hea”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002164
Bacillus subtilis PB6 EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“'- probiotic - for good intestinal health; - promotes and maintains intestinal health; - promotes and maintains intestinal function; - supports healthy gastrointestinal flora; - for good digestive health; - promotes and stimulates good bowel movement; -”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002165
Bacillus subtilis R0179 CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002166
Bacillus subtilis subsp. inaquosorum CA-NHP Not yet graded
CA licensed ingredient
Market presence212 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002167
Bacitracin US-DRUG Not yet graded
US: anda
also: Bacitracin Zinc
Class as recordedAmide Local Anesthetic [EPC]; Amides [CS]; Aminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]
Earliest US approval1948
Market presence387 US product listings · 38 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002168
Backhousia citriodora EU-NOVEL Not yet graded
Not novel in food
Parts in scopeShoots and leaves
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002169
Baclofen US-DRUG Not yet graded
US: anda
Class as recordedGABA A Agonists [MoA]; GABA B Agonists [MoA]; gamma-Aminobutyric Acid-ergic Agonist [EPC]
Earliest US approval1977
Market presence268 US product listings · 50 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002170
Bacopa monniera CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002171
Bacopa Monniera Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAntimalarial [EPC]; Catecholamine [EPC]; Catecholamines [CS]; Increased Uterine Smooth Muscle Contraction or Tone [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002172
Bacopa monniera linn CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002173
Bacopa monnieri CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
also: Allocalyx microphylla Cordem.
Market presence865 Canadian licensed products
Parts in scopeLeaves, herbs, rhizomes and tops
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-002174
Bacopa Monnieri Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAntimalarial [EPC]; Catecholamine [EPC]; Catecholamines [CS]; Increased Uterine Smooth Muscle Contraction or Tone [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002175
Bacopa monnieria CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002176
bacterial DNA plasmid containing LACK gene from Leishmania infantum EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002177
Bacterial lysate EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Strenghtens the body's natural resistance/supports the immune function”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002178
Bacterial Protease CA-NHP Not yet graded
CA licensed ingredient
Market presence821 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002179
Bactris balanoidea EU-NOVEL Not yet graded
Status not stated
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002180
Bactris gasipaes EU-NOVEL Not yet graded
Not novel in supplements
Parts in scopeWhole; Stems and fruits
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002181
Bactris major EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002182
Badiaga CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002183
Baicalin US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002184
Bakuchiol US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002185
Ballota Foetida US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antidote [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002186
Ballota nigra CA-NHP Not yet graded
CA licensed ingredient
Market presence40 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002187
Baloxavir Marboxil EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedChelating Activity [MoA]; Polymerase Acidic Endonuclease Inhibitor [EPC]; Polymerase Acidic Endonuclease Inhibitors [MoA]
Earliest US approval2018
Market presence15 US product listings · 3 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002188
Balsalazide Disodium US-DRUG Not yet graded
US: anda
Class as recordedAminosalicylate [EPC]; Aminosalicylic Acids [CS]
Earliest US approval2000
Market presence18 US product listings · 10 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002189
Balsam Peru US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antimalarial [EPC]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002190
Balsamorhiza sagittata CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002191
Balsamum peruvianum CA-NHPEU-HERB Not yet graded
Herbal monograph: F: Assessment finalisedCA licensed ingredient
also: Peru balsam; Myroxylon balsamum (L.) Harms var. perierae (Royle) Harms
Market presence11 Canadian licensed products
Recorded fromCA-NHP, EU-HERB — 2 of 7 registers
Etalyn identifierETA-C-002192
Balsamum toluifera CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002193
Bambusa bambos CA-NHP Not yet graded
CA licensed ingredient
Market presence18 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002194
Bambusa Bambos Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002195
Bambusa Bambos SAP US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002196
Bambusa Bambos Stem US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002197
Bambusa beecheyana CA-NHP Not yet graded
CA licensed ingredient
Market presence63 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002198
Bambusa breviflora CA-NHP Not yet graded
CA licensed ingredient
Market presence25 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002199
Bambusa spp. EU-NOVEL Not yet graded
Not novel in food
also: bamboe (NL); bambus (DE); Bamboo (EN) (PT)
Parts in scopeShoots; Leaves
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002200
Bambusa textilis CA-NHP Not yet graded
CA licensed ingredient
Market presence27 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002201
Bambusa tuldoides CA-NHP Not yet graded
CA licensed ingredient
Market presence54 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002202
Bambusa vulgaris CA-NHP Not yet graded
CA licensed ingredient
Market presence99 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002203
Bambusa Vulgaris Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002204
Bambusa vulgaris Schrad. ex J.C.Wendl. EU-NOVEL Not yet graded
Not novel in supplements
Parts in scopeLeaves, shoots and stems
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002205
Bambusa Vulgaris Stem US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002206
Bambusa Vulgaris TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002207
Bambusa Vulgaris Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002208
Bamlanivimab EU-MEDUS-DRUG Not yet graded
EU medicine: Withdrawn from rolling reviewUS: bulk ingredient
Market presence1 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002209
Banana EU-CLAIMUS-DRUG Not yet graded
EU claims 0 authorised / 1 refusedUS: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Ascorbic Acid [CS]
Market presence11 US product listings
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Banana is a major dietary source of antioxidants Antioxidants from dietary sources contribute to the protection against free radicals which cause cell damage Contributes to the protection of cells and tissues from oxidative damage Help strengthen our body's natural defences against oxidative stress”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002210
Bandtooth Conger US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002211
Baphicacanthus cusia CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002212
Baptisia Australis Root US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002213
Baptisia Tinctoria CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence34 US product listings · 97 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002214
Baptisia Tinctoria Root US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcidifying Activity [MoA]; Actively Acquired Immunity [PE]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Market presence240 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002215
Baptisia Tinctoria Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Allogeneic Cultured Cell Scaffold [EPC]
Market presence26 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002216
Barbarea verna CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002217
Barbital US-CSAUS-DRUG Not yet graded
CSA Schedule IVUS: bulk ingredient
Class as recordedDEA: depressant
Market presence4 US product listings
DEA other namesVeronal; Plexonal; barbitone
Recorded fromUS-CSA, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002218
Barbituric acid derivative US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: depressant
DEA other namesBarbiturates not specifically listed
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-002219
Bardoxolone methyl EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002220
Baricitinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedJanus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]; L04AA37
Earliest US approval2018
Market presence12 US product listings · 3 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002221
Barium CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bulk ingredient
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]
Earliest US approval2016
Market presence312 US product listings · 4 FDA applications · 8 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002222
Barium carbonicum CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002223
Barium chloratum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002224
Barium Iodate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002225
Barium iodatum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002226
Barium Oxalosuccinate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002227
Barium Phosphate, Dibasic US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002228
Barleria Lupulina Whole US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002229
Barley US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence19 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002230
Barley beta-glucan EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Odra kiudaine beeta-glükaani tarbimine suurendab küllastustunnet ehk täiskõhutunnet. Odra kiudaine beeta-glükaani tarbimine pikendab küllastustunde ehk täiskõhutunde säilimist. Clarification provided Consuming barley beta-glucan increases satiety. Consuming oats beta-glucan prolongs the feeling of satiety.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002231
Barley beta-glucans EU-CLAIM Not yet graded
EU claims 2 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Barley beta-glucans has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease.”AuthorisedArt.14(1)(a)EFSA opinion
“Barley beta-glucans has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease”AuthorisedArt.14(1)(a)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002232
Barley grain fibre EU-CLAIM Not yet graded
EU claims 1 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Barley grain fibre contributes to an increase in faecal bulk”AuthorisedArt.13(1)EFSA opinion
“Helps with weight control. For long-lasting sense of satiety. Frees energy slowly”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002233
Barley Malt US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Amino Acid Hypertonic Solution [EPC]; Amino Acids [CS]; Cell-mediated Immunity [PE]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002234
Barley soup "Orzotto" EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Contributes to the protection of blood lipids from oxidative damage .”Non-authorisedArt.13(5)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002235
BarleyTrim™ Barley Bran EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“The inclusion of 3 grams of barley beta glucan soluble fiber from BarleyTrim® Barley Bran, as a part of a diet low in saturated fat and a healthy lifestyle, can help maintain healthy blood glucose levels Barley beta glucan soluble fiber from BarleyTrim™ helps maintain healthy blood cholesterol levels.”Non-authorisedArt.13(1)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002236
Barosma betulina CA-NHPEU-NOVEL Not yet graded
Status not statedCA licensed ingredient
Market presence16 Canadian licensed products
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-002237
Barosma crenata CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002238
Bartonella Bacilliformis US-DRUG Not yet graded
US: drug for further processing
Market presence36 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002239
Bartonella Bacilliformis DNA US-DRUG Not yet graded
US: drug for further processing
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002240
Bartonella Clarridgeiae US-DRUG Not yet graded
US: drug for further processing
Market presence48 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002241
Bartonella Clarridgeiae DNA US-DRUG Not yet graded
US: drug for further processing
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002242
Bartonella Elizabethae US-DRUG Not yet graded
US: drug for further processing
Market presence48 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002243
Bartonella Henselae US-DRUG Not yet graded
US: drug for further processing
Market presence50 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002244
Bartonella Henselae DNA US-DRUG Not yet graded
US: drug for further processing
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002245
Bartonella Quintana US-DRUG Not yet graded
US: drug for further processing
Market presence48 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002246
Bartonella Quintana DNA US-DRUG Not yet graded
US: drug for further processing
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002247
Bartonella Vinsonii US-DRUG Not yet graded
US: drug for further processing
Market presence48 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002248
Bartonella Vinsonii DNA US-DRUG Not yet graded
US: drug for further processing
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002249
Bartonella Washoensis US-DRUG Not yet graded
US: drug for further processing
Market presence48 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002250
Bartonella Washoensis DNA US-DRUG Not yet graded
US: drug for further processing
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002251
Baryta acetica CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002252
Baryta carbonica CA-NHP Not yet graded
CA licensed ingredient
Market presence65 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002253
Baryta iodata CA-NHP Not yet graded
CA licensed ingredient
Market presence15 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002254
Baryta muriatica CA-NHP Not yet graded
CA licensed ingredient
Market presence24 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002255
Baryta phosphorica CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002256
Baryte CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002257
Basella alba CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
Market presence3 Canadian licensed products
Parts in scopeLeaves
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-002258
Basella rubra EU-NOVEL Not yet graded
Status not stated
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002259
Basic Copper Sulfate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCalculi Dissolution Agent [EPC]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002260
Basic Cupric Carbonate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Bee Venoms [CS]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002261
Basil US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002262
Basiliximab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedInterleukin 2 Receptor Antagonists [MoA]; Interleukin 2 Receptor-directed Antibody Interactions [MoA]; Interleukin-2 Receptor Blocking Antibody [EPC]; L04AC02
Earliest US approval1998
Market presence6 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002263
Bassia Hyssopifolia Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002264
Bassia scoparia CA-NHP Not yet graded
CA licensed ingredient
Market presence54 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002265
Bassia Scoparia Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002266
Bassia Scoparia Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence34 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002267
Bauhinia variegata CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002268
Bauxite CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002269
Baxdrostat US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2026
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002270
BAY Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002271
bazedoxifene EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bulk ingredient
Class as recordedConjugated (USP) [CS]; Estrogen Agonist/Antagonist [EPC]; Estrogen Receptor Agonists [MoA]; Estrogen [EPC]
Earliest US approval2013
Market presence5 US product listings · 1 FDA applications · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002272
BCG CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002273
Becaplermin EU-MEDUS-DRUG Not yet graded
EU medicine: Refused, WithdrawnUS: bla
Class as recordedD03AX06; Human Platelet-derived Growth Factor [EPC]; Platelet-Derived Growth Factor [CS]
Earliest US approval1997
Market presence2 US product listings · 1 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002274
beclometasone dipropionate EU-MED Not yet graded
EU medicine: Authorised, Withdrawn
Class as recordedR03AL09
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002275
Beclomethasone Dipropionate EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: anda
Class as recordedAdrenergic beta2-Agonists [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]
Earliest US approval1976
Market presence30 US product listings · 13 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002276
Bedaquiline Fumarate EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedDiarylquinoline Antimycobacterial [EPC]; Diarylquinolines [CS]; J04AK05
Earliest US approval2012
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002277
Bedinvetmab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Market presence1 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002278
BEE Pollen CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence4 US product listings · 133 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002279
Bee propolis CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002280
Beef US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Cells
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002281
Beef bile CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002282
Beef Heart US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Amino Acid [EPC]; Amino Acids [CS]
Market presence27 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002283
Beef Kidney US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Amino Acid [EPC]; Amino Acids [CS]
Market presence41 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002284
Beef Liver US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Actively Acquired Immunity [PE]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Market presence75 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002285
Beef Lung US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002286
Beef protein isolate CA-NHP Not yet graded
CA licensed ingredient
Market presence34 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002287
Beef Short Plate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCopper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002288
Beeswax US-DRUG Not yet graded
US: otc monograph drug
Class as recordedMethylating Activity [MoA]; Methylating Agent [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002289
Beeswax alcohols CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002290
Beet US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Analogs/Derivatives [Chemical/Ingredient]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002291
begelomab EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedL04AA35
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002292
Begonia fimbristipula CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002293
Belamcanda chinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002294
Belantamab Mafodotin EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, ExpiredUS: bla
Class as recordedL01FX15; L01XC39
Market presence2 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002295
Belantamab Mafodotin-Blmf US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002296
Belatacept EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedCD80-directed Antibody Interactions [MoA]; CD86-directed Antibody Interactions [MoA]; L04AA28; Selective T Cell Costimulation Blocker [EPC]
Earliest US approval2011
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002297
Beleric myrobalan CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002298
Belimumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedB Lymphocyte Stimulator-directed Antibody Interactions [MoA]; B Lymphocyte Stimulator-specific Inhibitor [EPC]; Decreased B Lymphocyte Activation [PE]; L04AG04
Earliest US approval2011
Market presence7 US product listings · 2 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002299
Belinostat US-DRUG Not yet graded
US: bulk ingredient
Class as recordedHistone Deacetylase Inhibitor [EPC]; Histone Deacetylase Inhibitors [MoA]
Earliest US approval2014
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002300
Belladonna CA-NHP Not yet graded
CA licensed ingredient
Market presence360 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002301
Belladonna Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedBlood Coagulation Factor [EPC]; Calcium [CS]; Cations; Divalent [CS]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002302
Belladonna-radix CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002303
Bellis Perennis CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence86 US product listings · 125 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002304
Bellis Perennis Flower US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002305
Bellis Perennis Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002306
Bellis Perennis Whole US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Bee Venoms [CS]
Market presence46 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002307
Belumosudil US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2021
Market presence6 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002308
belumosudil mesilate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL04AA48
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002309
Belzutifan EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 3A4 Inducers [MoA]; Hypoxia-inducible Factor 2 alpha Inhibitors [MoA]; Hypoxia-inducible Factor Inhibitor [EPC]; L01XX74
Earliest US approval2021
Market presence8 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002310
Bemotrizinol US-DRUG Not yet graded
US: otc monograph final
Class as recordedAcidifying Activity [MoA]; Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; Allergens [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002311
Bempedoic Acid EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedAdenosine Triphosphate-Citrate Lyase Inhibitor [EPC]; Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA]; C10AX; C10B
Earliest US approval2020
Market presence14 US product listings · 2 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002312
Bempedoic Acid, Ezetimibe US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002313
Benazepril EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAngiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]
Earliest US approval1991
Market presence222 US product listings · 36 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002314
Bendamustine Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedAlkylating Activity [MoA]; Alkylating Drug [EPC]
Earliest US approval2008
Market presence31 US product listings · 21 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002315
Bendroflumethiazide US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1959
Market presence2 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002316
Benfotiamine EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002317
Benincasa hispida CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: Benincasa cerifera Savi, Benincasa cylindrica hort. ex Ser., Benincasa hispida var. chieh-qua F.C.How, Benincasa hispida var. hispida.
Market presence56 Canadian licensed products
Parts in scopeFruits
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-002318
Benoxinate Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Class as recordedDiagnostic Dye [EPC]; Dyes [MoA]
Earliest US approval1975
Market presence4 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002319
Benralizumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedInterleukin 5 Receptor alpha-directed Antibody Interactions [MoA]; Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]; R03DX10
Earliest US approval2017
Market presence6 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-002320
Bentiromide US-DRUG Not yet graded
Earliest US approval1983
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002321
Bentonite CA-NHP Not yet graded
CA licensed ingredient
Market presence51 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002322
Bentoquatam US-DRUG Not yet graded
Earliest US approval1996
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002323
Benzalkonium Chloride US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]
Market presence1,214 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002324
Benzene US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Anti-coagulant [EPC]
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002325
Benzenecarbothioic acid S-[2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-1-[2-(phosphonooxy)ethyl]-1-propenyl] ester CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002327
Benzenecarboxylic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002328
Benzenemethanol, alpha-[1-(methylamino)ethyl]-, [R-(R*,S)]- CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002329